Brazil variant of coronavirus neutralised by Pfizer-BioNTech vaccine, says lab study

A laboratory study published in the New England Journal of Medicine has stated the COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus, which is spreading rapidly in Brazil. According to a report with Reuters, blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.

A laboratory study published in the New England Journal of Medicine has stated the COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus, which is spreading rapidly in Brazil. According to a report with Reuters, blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found. March 09, 2021 at 10:59AM https://ift.tt/3btiULw